Pyrazofurin

Pyrazofurin (pyrazomycin) is a natural product found in Streptomyces candidus, which is a nucleoside analogue related to ribavirin. It has antibiotic, antiviral

Pyrazofurin
Pyrazofurin
Clinical data
Trade namesPyrazofurin
Legal status
Legal status
Identifiers
  • 3-[(2S,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1H-pyrazole-5-carboxamide
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
Chemical and physical data
FormulaC9H13N3O6
Molar mass259.218 g·mol−1
3D model (JSmol)
  • C([C@@H]1[C@H]([C@H]([C@@H](O1)C2=NNC(=C2O)C(=O)N)O)O)O
  • InChI=1S/C9H13N3O6/c10-9(17)4-6(15)3(11-12-4)8-7(16)5(14)2(1-13)18-8/h2,5,7-8,13-16H,1H2,(H2,10,17)(H,11,12)/t2-,5-,7-,8+/m1/s1
  • Key:XESARGFCSKSFID-FLLFQEBCSA-N

Pyrazofurin (pyrazomycin) is a natural product found in Streptomyces candidus, which is a nucleoside analogue related to ribavirin. It has antibiotic, antiviral and anti-cancer properties but was not successful in human clinical trials due to severe side effects. Nevertheless, it continues to be the subject of ongoing research as a potential drug of last resort, or a template for improved synthetic derivatives.[1][2][3][4][5][6][7][8]

See also

References

  1. ^ Canonico PG, Jahrling PB, Pannier WL (December 1982). "Antiviral efficacy of pyrazofurin against selected RNA viruses". Antiviral Research. 2 (6): 331–7. doi:10.1016/0166-3542(82)90002-x. PMID 6299188.
  2. ^ Buchanan JG (1983). "The C-nucleoside antibiotics". Fortschritte der Chemie Organischer Naturstoffe. Fortschritte der Chemie organischer Naturstoffe / Progress in the Chemistry of Organic Natural Products. 44: 243–99. doi:10.1007/978-3-7091-8714-2_4. ISBN 978-3-7091-8716-6. PMID 6360831.{{cite journal}}: CS1 maint: periodical has ISBN (link)
  3. ^ Hacksell U, Daves GD (1985). "The chemistry and biochemistry of C-nucleosides and C-arylglycosides". Progress in Medicinal Chemistry. 22: 1–65. doi:10.1016/s0079-6468(08)70228-5. PMID 3915364.
  4. ^ De Clercq E (July 2009). "Another ten stories in antiviral drug discovery (part C): "Old" and "new" antivirals, strategies, and perspectives". Medicinal Research Reviews. 29 (4): 611–45. doi:10.1002/med.20153. PMID 19260077. S2CID 140127449.
  5. ^ De Clercq E (2015). "Curious (Old and New) Antiviral Nucleoside Analogues with Intriguing Therapeutic Potential". Current Medicinal Chemistry. 22 (34): 3866–80. doi:10.2174/0929867322666150625094705. PMID 26112146.
  6. ^ De Clercq E (March 2016). "C-Nucleosides To Be Revisited". Journal of Medicinal Chemistry. 59 (6): 2301–11. doi:10.1021/acs.jmedchem.5b01157. PMID 26513594.
  7. ^ De Clercq E (November 2019). "New Nucleoside Analogues for the Treatment of Hemorrhagic Fever Virus Infections". Chemistry: An Asian Journal. 14 (22): 3962–3968. doi:10.1002/asia.201900841. PMC 7159701. PMID 31389664.
  8. ^ Ren D, Wang SA, Ko Y, Geng Y, Ogasawara Y, Liu HW (November 2019). "Identification of the C-Glycoside Synthases during Biosynthesis of the Pyrazole-C-Nucleosides Formycin and Pyrazofurin". Angewandte Chemie. 58 (46): 16512–16516. doi:10.1002/anie.201910356. PMC 6911263. PMID 31518483.


Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.